nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—schizophrenia—Dimenhydrinate—atopic dermatitis	0.283	0.569	CpDpCtD
Haloperidol—schizophrenia—Diphenhydramine—atopic dermatitis	0.215	0.431	CpDpCtD
Haloperidol—HRH1—Dimenhydrinate—atopic dermatitis	0.0386	0.101	CbGbCtD
Haloperidol—KCNH2—Loratadine—atopic dermatitis	0.032	0.0837	CbGbCtD
Haloperidol—CYP3A7—Tacrolimus—atopic dermatitis	0.0224	0.0585	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0224	0.0585	CbGbCtD
Haloperidol—HRH1—Loratadine—atopic dermatitis	0.0189	0.0493	CbGbCtD
Haloperidol—HRH1—Diphenhydramine—atopic dermatitis	0.0189	0.0493	CbGbCtD
Haloperidol—CYP3A5—Tacrolimus—atopic dermatitis	0.0168	0.0439	CbGbCtD
Haloperidol—CYP3A4—Pimecrolimus—atopic dermatitis	0.011	0.0288	CbGbCtD
Haloperidol—ABCB1—Tacrolimus—atopic dermatitis	0.0109	0.0285	CbGbCtD
Haloperidol—CYP2C19—Diphenhydramine—atopic dermatitis	0.00991	0.0259	CbGbCtD
Haloperidol—CYP2C19—Loratadine—atopic dermatitis	0.00991	0.0259	CbGbCtD
Haloperidol—CYP1A2—Diphenhydramine—atopic dermatitis	0.00914	0.0239	CbGbCtD
Haloperidol—CYP3A7—Hydrocortisone—atopic dermatitis	0.00911	0.0238	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00911	0.0238	CbGbCtD
Haloperidol—CYP2C9—Loratadine—atopic dermatitis	0.00824	0.0215	CbGbCtD
Haloperidol—CYP2C9—Diphenhydramine—atopic dermatitis	0.00824	0.0215	CbGbCtD
Haloperidol—ABCB1—Loratadine—atopic dermatitis	0.00799	0.0209	CbGbCtD
Haloperidol—CYP2D6—Diphenhydramine—atopic dermatitis	0.00753	0.0197	CbGbCtD
Haloperidol—CYP2D6—Loratadine—atopic dermatitis	0.00753	0.0197	CbGbCtD
Haloperidol—ABCB1—Methylprednisolone—atopic dermatitis	0.00731	0.0191	CbGbCtD
Haloperidol—CYP1A1—Dexamethasone—atopic dermatitis	0.00708	0.0185	CbGbCtD
Haloperidol—CYP3A5—Hydrocortisone—atopic dermatitis	0.00683	0.0179	CbGbCtD
Haloperidol—CYP3A4—Tacrolimus—atopic dermatitis	0.00654	0.0171	CbGbCtD
Haloperidol—CYP3A7—Dexamethasone—atopic dermatitis	0.00566	0.0148	CbGbCtD
Haloperidol—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00566	0.0148	CbGbCtD
Haloperidol—CYP2C19—Prednisone—atopic dermatitis	0.00549	0.0144	CbGbCtD
Haloperidol—CYP3A4—Loratadine—atopic dermatitis	0.00479	0.0125	CbGbCtD
Haloperidol—ABCB1—Betamethasone—atopic dermatitis	0.00475	0.0124	CbGbCtD
Haloperidol—ABCB1—Prednisolone—atopic dermatitis	0.00469	0.0123	CbGbCtD
Haloperidol—ABCB1—Hydrocortisone—atopic dermatitis	0.00445	0.0116	CbGbCtD
Haloperidol—ABCB1—Prednisone—atopic dermatitis	0.00443	0.0116	CbGbCtD
Haloperidol—CYP3A4—Methylprednisolone—atopic dermatitis	0.00438	0.0115	CbGbCtD
Haloperidol—CYP3A5—Dexamethasone—atopic dermatitis	0.00425	0.0111	CbGbCtD
Haloperidol—CYP2C19—Dexamethasone—atopic dermatitis	0.00343	0.00896	CbGbCtD
Haloperidol—CYP3A4—Triamcinolone—atopic dermatitis	0.00332	0.00868	CbGbCtD
Haloperidol—CYP2C9—Dexamethasone—atopic dermatitis	0.00285	0.00745	CbGbCtD
Haloperidol—CYP3A4—Betamethasone—atopic dermatitis	0.00285	0.00745	CbGbCtD
Haloperidol—CYP3A4—Prednisolone—atopic dermatitis	0.00281	0.00735	CbGbCtD
Haloperidol—ABCB1—Dexamethasone—atopic dermatitis	0.00276	0.00723	CbGbCtD
Haloperidol—CYP3A4—Hydrocortisone—atopic dermatitis	0.00266	0.00696	CbGbCtD
Haloperidol—CYP3A4—Prednisone—atopic dermatitis	0.00265	0.00694	CbGbCtD
Haloperidol—CYP2D6—Dexamethasone—atopic dermatitis	0.0026	0.00681	CbGbCtD
Haloperidol—CYP3A4—Dexamethasone—atopic dermatitis	0.00166	0.00433	CbGbCtD
Haloperidol—EBP—Temsirolimus—Tacrolimus—atopic dermatitis	0.000573	0.238	CbGdCrCtD
Haloperidol—EBP—Sirolimus—Pimecrolimus—atopic dermatitis	0.000573	0.238	CbGdCrCtD
Haloperidol—EBP—Sirolimus—Tacrolimus—atopic dermatitis	0.000573	0.238	CbGdCrCtD
Haloperidol—EBP—Temsirolimus—Pimecrolimus—atopic dermatitis	0.000573	0.238	CbGdCrCtD
Haloperidol—SIGMAR1—Levonorgestrel—Hydrocortisone—atopic dermatitis	0.000115	0.048	CbGdCrCtD
Haloperidol—Visual impairment—Prednisolone—atopic dermatitis	0.000106	0.00119	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000106	0.00119	CcSEcCtD
Haloperidol—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000106	0.00119	CcSEcCtD
Haloperidol—Diarrhoea—Mometasone—atopic dermatitis	0.000105	0.00118	CcSEcCtD
Haloperidol—Constipation—Tacrolimus—atopic dermatitis	0.000105	0.00117	CcSEcCtD
Haloperidol—Weight increased—Dexamethasone—atopic dermatitis	0.000105	0.00117	CcSEcCtD
Haloperidol—Weight increased—Betamethasone—atopic dermatitis	0.000105	0.00117	CcSEcCtD
Haloperidol—Weight decreased—Dexamethasone—atopic dermatitis	0.000104	0.00116	CcSEcCtD
Haloperidol—Weight decreased—Betamethasone—atopic dermatitis	0.000104	0.00116	CcSEcCtD
Haloperidol—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000104	0.00116	CcSEcCtD
Haloperidol—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000104	0.00116	CcSEcCtD
Haloperidol—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000103	0.00115	CcSEcCtD
Haloperidol—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000102	0.00114	CcSEcCtD
Haloperidol—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000102	0.00114	CcSEcCtD
Haloperidol—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000101	0.00113	CcSEcCtD
Haloperidol—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000101	0.00113	CcSEcCtD
Haloperidol—Hallucination—Methylprednisolone—atopic dermatitis	0.000101	0.00113	CcSEcCtD
Haloperidol—Eye disorder—Hydrocortisone—atopic dermatitis	0.000101	0.00113	CcSEcCtD
Haloperidol—Connective tissue disorder—Methylprednisolone—atopic dermatitis	9.94e-05	0.00111	CcSEcCtD
Haloperidol—Vomiting—Mometasone—atopic dermatitis	9.8e-05	0.0011	CcSEcCtD
Haloperidol—Sweating increased—Prednisone—atopic dermatitis	9.75e-05	0.00109	CcSEcCtD
Haloperidol—Visual impairment—Methylprednisolone—atopic dermatitis	9.75e-05	0.00109	CcSEcCtD
Haloperidol—Urticaria—Tacrolimus—atopic dermatitis	9.74e-05	0.00109	CcSEcCtD
Haloperidol—Immune system disorder—Hydrocortisone—atopic dermatitis	9.73e-05	0.00109	CcSEcCtD
Haloperidol—Rash—Mometasone—atopic dermatitis	9.71e-05	0.00109	CcSEcCtD
Haloperidol—Dermatitis—Mometasone—atopic dermatitis	9.71e-05	0.00109	CcSEcCtD
Haloperidol—Body temperature increased—Tacrolimus—atopic dermatitis	9.69e-05	0.00109	CcSEcCtD
Haloperidol—Headache—Mometasone—atopic dermatitis	9.65e-05	0.00108	CcSEcCtD
Haloperidol—Nausea—Fluocinolone Acetonide—atopic dermatitis	9.58e-05	0.00107	CcSEcCtD
Haloperidol—Eye disorder—Methylprednisolone—atopic dermatitis	9.45e-05	0.00106	CcSEcCtD
Haloperidol—Mental disorder—Hydrocortisone—atopic dermatitis	9.43e-05	0.00106	CcSEcCtD
Haloperidol—Cardiac disorder—Methylprednisolone—atopic dermatitis	9.39e-05	0.00105	CcSEcCtD
Haloperidol—Malnutrition—Hydrocortisone—atopic dermatitis	9.37e-05	0.00105	CcSEcCtD
Haloperidol—Neutropenia—Prednisone—atopic dermatitis	9.36e-05	0.00105	CcSEcCtD
Haloperidol—Erectile dysfunction—Prednisone—atopic dermatitis	9.22e-05	0.00103	CcSEcCtD
Haloperidol—Angiopathy—Methylprednisolone—atopic dermatitis	9.18e-05	0.00103	CcSEcCtD
Haloperidol—Hallucination—Betamethasone—atopic dermatitis	9.15e-05	0.00103	CcSEcCtD
Haloperidol—Hallucination—Dexamethasone—atopic dermatitis	9.15e-05	0.00103	CcSEcCtD
Haloperidol—Nausea—Mometasone—atopic dermatitis	9.15e-05	0.00103	CcSEcCtD
Haloperidol—Immune system disorder—Methylprednisolone—atopic dermatitis	9.14e-05	0.00102	CcSEcCtD
Haloperidol—Mediastinal disorder—Methylprednisolone—atopic dermatitis	9.12e-05	0.00102	CcSEcCtD
Haloperidol—Weight increased—Prednisone—atopic dermatitis	9.11e-05	0.00102	CcSEcCtD
Haloperidol—Weight decreased—Prednisone—atopic dermatitis	9.06e-05	0.00101	CcSEcCtD
Haloperidol—Vision blurred—Prednisolone—atopic dermatitis	9.05e-05	0.00101	CcSEcCtD
Haloperidol—Hypersensitivity—Tacrolimus—atopic dermatitis	9.03e-05	0.00101	CcSEcCtD
Haloperidol—Hyperglycaemia—Prednisone—atopic dermatitis	9.03e-05	0.00101	CcSEcCtD
Haloperidol—Depression—Prednisone—atopic dermatitis	8.9e-05	0.000997	CcSEcCtD
Haloperidol—Visual impairment—Betamethasone—atopic dermatitis	8.87e-05	0.000993	CcSEcCtD
Haloperidol—Visual impairment—Dexamethasone—atopic dermatitis	8.87e-05	0.000993	CcSEcCtD
Haloperidol—Mental disorder—Methylprednisolone—atopic dermatitis	8.86e-05	0.000993	CcSEcCtD
Haloperidol—Malnutrition—Methylprednisolone—atopic dermatitis	8.81e-05	0.000986	CcSEcCtD
Haloperidol—Pruritus—Tacrolimus—atopic dermatitis	8.68e-05	0.000972	CcSEcCtD
Haloperidol—Vertigo—Prednisolone—atopic dermatitis	8.62e-05	0.000966	CcSEcCtD
Haloperidol—Eye disorder—Betamethasone—atopic dermatitis	8.6e-05	0.000963	CcSEcCtD
Haloperidol—Eye disorder—Dexamethasone—atopic dermatitis	8.6e-05	0.000963	CcSEcCtD
Haloperidol—Vertigo—Hydrocortisone—atopic dermatitis	8.42e-05	0.000943	CcSEcCtD
Haloperidol—Diarrhoea—Tacrolimus—atopic dermatitis	8.39e-05	0.00094	CcSEcCtD
Haloperidol—Angiopathy—Dexamethasone—atopic dermatitis	8.35e-05	0.000935	CcSEcCtD
Haloperidol—Angiopathy—Betamethasone—atopic dermatitis	8.35e-05	0.000935	CcSEcCtD
Haloperidol—Convulsion—Prednisolone—atopic dermatitis	8.32e-05	0.000931	CcSEcCtD
Haloperidol—Hypertension—Prednisolone—atopic dermatitis	8.29e-05	0.000928	CcSEcCtD
Haloperidol—Alopecia—Betamethasone—atopic dermatitis	8.13e-05	0.000911	CcSEcCtD
Haloperidol—Alopecia—Dexamethasone—atopic dermatitis	8.13e-05	0.000911	CcSEcCtD
Haloperidol—Convulsion—Hydrocortisone—atopic dermatitis	8.12e-05	0.00091	CcSEcCtD
Haloperidol—Dizziness—Tacrolimus—atopic dermatitis	8.11e-05	0.000908	CcSEcCtD
Haloperidol—Hypertension—Hydrocortisone—atopic dermatitis	8.09e-05	0.000906	CcSEcCtD
Haloperidol—Hallucination—Prednisone—atopic dermatitis	7.97e-05	0.000893	CcSEcCtD
Haloperidol—Anxiety—Hydrocortisone—atopic dermatitis	7.95e-05	0.000891	CcSEcCtD
Haloperidol—Vertigo—Triamcinolone—atopic dermatitis	7.93e-05	0.000888	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	7.93e-05	0.000888	CcSEcCtD
Haloperidol—Vertigo—Methylprednisolone—atopic dermatitis	7.91e-05	0.000886	CcSEcCtD
Haloperidol—Connective tissue disorder—Prednisone—atopic dermatitis	7.87e-05	0.000882	CcSEcCtD
Haloperidol—Anaphylactic shock—Prednisolone—atopic dermatitis	7.83e-05	0.000877	CcSEcCtD
Haloperidol—Oedema—Prednisolone—atopic dermatitis	7.83e-05	0.000877	CcSEcCtD
Haloperidol—Vomiting—Tacrolimus—atopic dermatitis	7.8e-05	0.000873	CcSEcCtD
Haloperidol—Rash—Tacrolimus—atopic dermatitis	7.73e-05	0.000866	CcSEcCtD
Haloperidol—Dermatitis—Tacrolimus—atopic dermatitis	7.72e-05	0.000865	CcSEcCtD
Haloperidol—Headache—Tacrolimus—atopic dermatitis	7.68e-05	0.00086	CcSEcCtD
Haloperidol—Oedema—Hydrocortisone—atopic dermatitis	7.65e-05	0.000857	CcSEcCtD
Haloperidol—Anaphylactic shock—Hydrocortisone—atopic dermatitis	7.65e-05	0.000857	CcSEcCtD
Haloperidol—Convulsion—Triamcinolone—atopic dermatitis	7.65e-05	0.000856	CcSEcCtD
Haloperidol—Tachycardia—Prednisolone—atopic dermatitis	7.64e-05	0.000856	CcSEcCtD
Haloperidol—Convulsion—Methylprednisolone—atopic dermatitis	7.63e-05	0.000855	CcSEcCtD
Haloperidol—Hypertension—Triamcinolone—atopic dermatitis	7.62e-05	0.000853	CcSEcCtD
Haloperidol—Hypertension—Methylprednisolone—atopic dermatitis	7.6e-05	0.000852	CcSEcCtD
Haloperidol—Hyperhidrosis—Prednisolone—atopic dermatitis	7.57e-05	0.000848	CcSEcCtD
Haloperidol—Nervous system disorder—Hydrocortisone—atopic dermatitis	7.5e-05	0.00084	CcSEcCtD
Haloperidol—Eye disorder—Prednisone—atopic dermatitis	7.49e-05	0.000839	CcSEcCtD
Haloperidol—Anxiety—Methylprednisolone—atopic dermatitis	7.47e-05	0.000837	CcSEcCtD
Haloperidol—Tachycardia—Hydrocortisone—atopic dermatitis	7.47e-05	0.000836	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	7.45e-05	0.000834	CcSEcCtD
Haloperidol—Skin disorder—Hydrocortisone—atopic dermatitis	7.43e-05	0.000832	CcSEcCtD
Haloperidol—Hyperhidrosis—Hydrocortisone—atopic dermatitis	7.4e-05	0.000828	CcSEcCtD
Haloperidol—Dry mouth—Triamcinolone—atopic dermatitis	7.35e-05	0.000823	CcSEcCtD
Haloperidol—Anorexia—Hydrocortisone—atopic dermatitis	7.29e-05	0.000817	CcSEcCtD
Haloperidol—Nausea—Tacrolimus—atopic dermatitis	7.28e-05	0.000816	CcSEcCtD
Haloperidol—Angiopathy—Prednisone—atopic dermatitis	7.27e-05	0.000814	CcSEcCtD
Haloperidol—Confusional state—Methylprednisolone—atopic dermatitis	7.25e-05	0.000812	CcSEcCtD
Haloperidol—Immune system disorder—Prednisone—atopic dermatitis	7.24e-05	0.000811	CcSEcCtD
Haloperidol—Oedema—Triamcinolone—atopic dermatitis	7.2e-05	0.000807	CcSEcCtD
Haloperidol—Anaphylactic shock—Triamcinolone—atopic dermatitis	7.2e-05	0.000807	CcSEcCtD
Haloperidol—Vertigo—Dexamethasone—atopic dermatitis	7.2e-05	0.000806	CcSEcCtD
Haloperidol—Vertigo—Betamethasone—atopic dermatitis	7.2e-05	0.000806	CcSEcCtD
Haloperidol—Anaphylactic shock—Methylprednisolone—atopic dermatitis	7.19e-05	0.000805	CcSEcCtD
Haloperidol—Hypotension—Hydrocortisone—atopic dermatitis	7.15e-05	0.000801	CcSEcCtD
Haloperidol—Insomnia—Prednisolone—atopic dermatitis	7.08e-05	0.000793	CcSEcCtD
Haloperidol—Alopecia—Prednisone—atopic dermatitis	7.08e-05	0.000793	CcSEcCtD
Haloperidol—Nervous system disorder—Methylprednisolone—atopic dermatitis	7.05e-05	0.000789	CcSEcCtD
Haloperidol—Tachycardia—Triamcinolone—atopic dermatitis	7.03e-05	0.000787	CcSEcCtD
Haloperidol—Mental disorder—Prednisone—atopic dermatitis	7.02e-05	0.000786	CcSEcCtD
Haloperidol—Tachycardia—Methylprednisolone—atopic dermatitis	7.01e-05	0.000786	CcSEcCtD
Haloperidol—Skin disorder—Methylprednisolone—atopic dermatitis	6.98e-05	0.000782	CcSEcCtD
Haloperidol—Malnutrition—Prednisone—atopic dermatitis	6.97e-05	0.000781	CcSEcCtD
Haloperidol—Hyperhidrosis—Triamcinolone—atopic dermatitis	6.96e-05	0.00078	CcSEcCtD
Haloperidol—Hyperhidrosis—Methylprednisolone—atopic dermatitis	6.95e-05	0.000778	CcSEcCtD
Haloperidol—Convulsion—Betamethasone—atopic dermatitis	6.94e-05	0.000777	CcSEcCtD
Haloperidol—Convulsion—Dexamethasone—atopic dermatitis	6.94e-05	0.000777	CcSEcCtD
Haloperidol—Insomnia—Hydrocortisone—atopic dermatitis	6.92e-05	0.000775	CcSEcCtD
Haloperidol—Hypertension—Dexamethasone—atopic dermatitis	6.91e-05	0.000774	CcSEcCtD
Haloperidol—Hypertension—Betamethasone—atopic dermatitis	6.91e-05	0.000774	CcSEcCtD
Haloperidol—Anxiety—Dexamethasone—atopic dermatitis	6.79e-05	0.000761	CcSEcCtD
Haloperidol—Anxiety—Betamethasone—atopic dermatitis	6.79e-05	0.000761	CcSEcCtD
Haloperidol—Dyspepsia—Hydrocortisone—atopic dermatitis	6.73e-05	0.000754	CcSEcCtD
Haloperidol—Hypotension—Methylprednisolone—atopic dermatitis	6.72e-05	0.000752	CcSEcCtD
Haloperidol—Decreased appetite—Hydrocortisone—atopic dermatitis	6.65e-05	0.000745	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	6.6e-05	0.00074	CcSEcCtD
Haloperidol—Vision blurred—Prednisone—atopic dermatitis	6.57e-05	0.000736	CcSEcCtD
Haloperidol—Anaphylactic shock—Betamethasone—atopic dermatitis	6.54e-05	0.000732	CcSEcCtD
Haloperidol—Oedema—Betamethasone—atopic dermatitis	6.54e-05	0.000732	CcSEcCtD
Haloperidol—Oedema—Dexamethasone—atopic dermatitis	6.54e-05	0.000732	CcSEcCtD
Haloperidol—Anaphylactic shock—Dexamethasone—atopic dermatitis	6.54e-05	0.000732	CcSEcCtD
Haloperidol—Insomnia—Triamcinolone—atopic dermatitis	6.52e-05	0.00073	CcSEcCtD
Haloperidol—Insomnia—Methylprednisolone—atopic dermatitis	6.5e-05	0.000728	CcSEcCtD
Haloperidol—Feeling abnormal—Prednisolone—atopic dermatitis	6.45e-05	0.000723	CcSEcCtD
Haloperidol—Anaemia—Prednisone—atopic dermatitis	6.45e-05	0.000722	CcSEcCtD
Haloperidol—Dyspnoea—Triamcinolone—atopic dermatitis	6.42e-05	0.000719	CcSEcCtD
Haloperidol—Nervous system disorder—Dexamethasone—atopic dermatitis	6.41e-05	0.000718	CcSEcCtD
Haloperidol—Nervous system disorder—Betamethasone—atopic dermatitis	6.41e-05	0.000718	CcSEcCtD
Haloperidol—Agitation—Prednisone—atopic dermatitis	6.41e-05	0.000718	CcSEcCtD
Haloperidol—Thrombocytopenia—Dexamethasone—atopic dermatitis	6.4e-05	0.000717	CcSEcCtD
Haloperidol—Thrombocytopenia—Betamethasone—atopic dermatitis	6.4e-05	0.000717	CcSEcCtD
Haloperidol—Tachycardia—Betamethasone—atopic dermatitis	6.38e-05	0.000714	CcSEcCtD
Haloperidol—Tachycardia—Dexamethasone—atopic dermatitis	6.38e-05	0.000714	CcSEcCtD
Haloperidol—Dyspepsia—Triamcinolone—atopic dermatitis	6.34e-05	0.00071	CcSEcCtD
Haloperidol—Dyspepsia—Methylprednisolone—atopic dermatitis	6.33e-05	0.000709	CcSEcCtD
Haloperidol—Hyperhidrosis—Dexamethasone—atopic dermatitis	6.32e-05	0.000708	CcSEcCtD
Haloperidol—Hyperhidrosis—Betamethasone—atopic dermatitis	6.32e-05	0.000708	CcSEcCtD
Haloperidol—Feeling abnormal—Hydrocortisone—atopic dermatitis	6.3e-05	0.000706	CcSEcCtD
Haloperidol—Vertigo—Prednisone—atopic dermatitis	6.27e-05	0.000702	CcSEcCtD
Haloperidol—Anorexia—Dexamethasone—atopic dermatitis	6.23e-05	0.000698	CcSEcCtD
Haloperidol—Anorexia—Betamethasone—atopic dermatitis	6.23e-05	0.000698	CcSEcCtD
Haloperidol—Urticaria—Prednisolone—atopic dermatitis	6.22e-05	0.000697	CcSEcCtD
Haloperidol—Hypotension—Betamethasone—atopic dermatitis	6.11e-05	0.000684	CcSEcCtD
Haloperidol—Hypotension—Dexamethasone—atopic dermatitis	6.11e-05	0.000684	CcSEcCtD
Haloperidol—Urticaria—Hydrocortisone—atopic dermatitis	6.08e-05	0.000681	CcSEcCtD
Haloperidol—Body temperature increased—Hydrocortisone—atopic dermatitis	6.05e-05	0.000677	CcSEcCtD
Haloperidol—Convulsion—Prednisone—atopic dermatitis	6.04e-05	0.000677	CcSEcCtD
Haloperidol—Hypertension—Prednisone—atopic dermatitis	6.02e-05	0.000674	CcSEcCtD
Haloperidol—Feeling abnormal—Triamcinolone—atopic dermatitis	5.94e-05	0.000665	CcSEcCtD
Haloperidol—Feeling abnormal—Methylprednisolone—atopic dermatitis	5.92e-05	0.000663	CcSEcCtD
Haloperidol—Anxiety—Prednisone—atopic dermatitis	5.92e-05	0.000663	CcSEcCtD
Haloperidol—Insomnia—Betamethasone—atopic dermatitis	5.91e-05	0.000662	CcSEcCtD
Haloperidol—Insomnia—Dexamethasone—atopic dermatitis	5.91e-05	0.000662	CcSEcCtD
Haloperidol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	5.9e-05	0.00066	CcSEcCtD
Haloperidol—Hypersensitivity—Prednisolone—atopic dermatitis	5.77e-05	0.000646	CcSEcCtD
Haloperidol—Dyspepsia—Dexamethasone—atopic dermatitis	5.75e-05	0.000644	CcSEcCtD
Haloperidol—Dyspepsia—Betamethasone—atopic dermatitis	5.75e-05	0.000644	CcSEcCtD
Haloperidol—Urticaria—Triamcinolone—atopic dermatitis	5.72e-05	0.000641	CcSEcCtD
Haloperidol—Urticaria—Methylprednisolone—atopic dermatitis	5.71e-05	0.000639	CcSEcCtD
Haloperidol—Body temperature increased—Triamcinolone—atopic dermatitis	5.69e-05	0.000638	CcSEcCtD
Haloperidol—Oedema—Prednisone—atopic dermatitis	5.69e-05	0.000638	CcSEcCtD
Haloperidol—Anaphylactic shock—Prednisone—atopic dermatitis	5.69e-05	0.000638	CcSEcCtD
Haloperidol—Decreased appetite—Betamethasone—atopic dermatitis	5.68e-05	0.000636	CcSEcCtD
Haloperidol—Decreased appetite—Dexamethasone—atopic dermatitis	5.68e-05	0.000636	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Betamethasone—atopic dermatitis	5.64e-05	0.000632	CcSEcCtD
Haloperidol—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	5.64e-05	0.000632	CcSEcCtD
Haloperidol—Hypersensitivity—Hydrocortisone—atopic dermatitis	5.64e-05	0.000631	CcSEcCtD
Haloperidol—Nervous system disorder—Prednisone—atopic dermatitis	5.58e-05	0.000625	CcSEcCtD
Haloperidol—Tachycardia—Prednisone—atopic dermatitis	5.56e-05	0.000622	CcSEcCtD
Haloperidol—Skin disorder—Prednisone—atopic dermatitis	5.53e-05	0.000619	CcSEcCtD
Haloperidol—Hyperhidrosis—Prednisone—atopic dermatitis	5.5e-05	0.000616	CcSEcCtD
Haloperidol—Anorexia—Prednisone—atopic dermatitis	5.43e-05	0.000608	CcSEcCtD
Haloperidol—Pruritus—Hydrocortisone—atopic dermatitis	5.41e-05	0.000606	CcSEcCtD
Haloperidol—Feeling abnormal—Dexamethasone—atopic dermatitis	5.39e-05	0.000603	CcSEcCtD
Haloperidol—Feeling abnormal—Betamethasone—atopic dermatitis	5.39e-05	0.000603	CcSEcCtD
Haloperidol—Hypersensitivity—Triamcinolone—atopic dermatitis	5.31e-05	0.000594	CcSEcCtD
Haloperidol—Hypersensitivity—Methylprednisolone—atopic dermatitis	5.3e-05	0.000593	CcSEcCtD
Haloperidol—Diarrhoea—Hydrocortisone—atopic dermatitis	5.23e-05	0.000586	CcSEcCtD
Haloperidol—Urticaria—Dexamethasone—atopic dermatitis	5.19e-05	0.000582	CcSEcCtD
Haloperidol—Urticaria—Betamethasone—atopic dermatitis	5.19e-05	0.000582	CcSEcCtD
Haloperidol—Dizziness—Prednisolone—atopic dermatitis	5.18e-05	0.00058	CcSEcCtD
Haloperidol—Body temperature increased—Dexamethasone—atopic dermatitis	5.17e-05	0.000579	CcSEcCtD
Haloperidol—Body temperature increased—Betamethasone—atopic dermatitis	5.17e-05	0.000579	CcSEcCtD
Haloperidol—Insomnia—Prednisone—atopic dermatitis	5.15e-05	0.000577	CcSEcCtD
Haloperidol—Pruritus—Triamcinolone—atopic dermatitis	5.1e-05	0.000571	CcSEcCtD
Haloperidol—Pruritus—Methylprednisolone—atopic dermatitis	5.08e-05	0.00057	CcSEcCtD
Haloperidol—Dizziness—Hydrocortisone—atopic dermatitis	5.06e-05	0.000567	CcSEcCtD
Haloperidol—Dyspepsia—Prednisone—atopic dermatitis	5.01e-05	0.000561	CcSEcCtD
Haloperidol—Decreased appetite—Prednisone—atopic dermatitis	4.95e-05	0.000554	CcSEcCtD
Haloperidol—Rash—Prednisolone—atopic dermatitis	4.94e-05	0.000553	CcSEcCtD
Haloperidol—Dermatitis—Prednisolone—atopic dermatitis	4.93e-05	0.000553	CcSEcCtD
Haloperidol—Diarrhoea—Methylprednisolone—atopic dermatitis	4.92e-05	0.000551	CcSEcCtD
Haloperidol—Headache—Prednisolone—atopic dermatitis	4.91e-05	0.00055	CcSEcCtD
Haloperidol—Constipation—Prednisone—atopic dermatitis	4.87e-05	0.000545	CcSEcCtD
Haloperidol—Vomiting—Hydrocortisone—atopic dermatitis	4.86e-05	0.000545	CcSEcCtD
Haloperidol—Rash—Hydrocortisone—atopic dermatitis	4.82e-05	0.00054	CcSEcCtD
Haloperidol—Dermatitis—Hydrocortisone—atopic dermatitis	4.82e-05	0.00054	CcSEcCtD
Haloperidol—Headache—Hydrocortisone—atopic dermatitis	4.79e-05	0.000537	CcSEcCtD
Haloperidol—Dizziness—Triamcinolone—atopic dermatitis	4.76e-05	0.000534	CcSEcCtD
Haloperidol—Dizziness—Methylprednisolone—atopic dermatitis	4.75e-05	0.000532	CcSEcCtD
Haloperidol—Feeling abnormal—Prednisone—atopic dermatitis	4.69e-05	0.000525	CcSEcCtD
Haloperidol—Nausea—Prednisolone—atopic dermatitis	4.65e-05	0.000521	CcSEcCtD
Haloperidol—Pruritus—Betamethasone—atopic dermatitis	4.62e-05	0.000518	CcSEcCtD
Haloperidol—Pruritus—Dexamethasone—atopic dermatitis	4.62e-05	0.000518	CcSEcCtD
Haloperidol—Vomiting—Triamcinolone—atopic dermatitis	4.58e-05	0.000513	CcSEcCtD
Haloperidol—Vomiting—Methylprednisolone—atopic dermatitis	4.57e-05	0.000512	CcSEcCtD
Haloperidol—Nausea—Hydrocortisone—atopic dermatitis	4.54e-05	0.000509	CcSEcCtD
Haloperidol—Rash—Triamcinolone—atopic dermatitis	4.54e-05	0.000509	CcSEcCtD
Haloperidol—Dermatitis—Triamcinolone—atopic dermatitis	4.54e-05	0.000508	CcSEcCtD
Haloperidol—Rash—Methylprednisolone—atopic dermatitis	4.53e-05	0.000508	CcSEcCtD
Haloperidol—Dermatitis—Methylprednisolone—atopic dermatitis	4.53e-05	0.000507	CcSEcCtD
Haloperidol—Urticaria—Prednisone—atopic dermatitis	4.52e-05	0.000506	CcSEcCtD
Haloperidol—Headache—Triamcinolone—atopic dermatitis	4.51e-05	0.000505	CcSEcCtD
Haloperidol—Headache—Methylprednisolone—atopic dermatitis	4.5e-05	0.000504	CcSEcCtD
Haloperidol—Body temperature increased—Prednisone—atopic dermatitis	4.5e-05	0.000504	CcSEcCtD
Haloperidol—Diarrhoea—Dexamethasone—atopic dermatitis	4.47e-05	0.000501	CcSEcCtD
Haloperidol—Diarrhoea—Betamethasone—atopic dermatitis	4.47e-05	0.000501	CcSEcCtD
Haloperidol—Dizziness—Betamethasone—atopic dermatitis	4.32e-05	0.000484	CcSEcCtD
Haloperidol—Dizziness—Dexamethasone—atopic dermatitis	4.32e-05	0.000484	CcSEcCtD
Haloperidol—Nausea—Triamcinolone—atopic dermatitis	4.28e-05	0.000479	CcSEcCtD
Haloperidol—Nausea—Methylprednisolone—atopic dermatitis	4.27e-05	0.000478	CcSEcCtD
Haloperidol—Hypersensitivity—Prednisone—atopic dermatitis	4.19e-05	0.00047	CcSEcCtD
Haloperidol—Vomiting—Dexamethasone—atopic dermatitis	4.16e-05	0.000465	CcSEcCtD
Haloperidol—Vomiting—Betamethasone—atopic dermatitis	4.16e-05	0.000465	CcSEcCtD
Haloperidol—Rash—Betamethasone—atopic dermatitis	4.12e-05	0.000462	CcSEcCtD
Haloperidol—Rash—Dexamethasone—atopic dermatitis	4.12e-05	0.000462	CcSEcCtD
Haloperidol—Dermatitis—Dexamethasone—atopic dermatitis	4.12e-05	0.000461	CcSEcCtD
Haloperidol—Dermatitis—Betamethasone—atopic dermatitis	4.12e-05	0.000461	CcSEcCtD
Haloperidol—Headache—Dexamethasone—atopic dermatitis	4.09e-05	0.000459	CcSEcCtD
Haloperidol—Headache—Betamethasone—atopic dermatitis	4.09e-05	0.000459	CcSEcCtD
Haloperidol—Pruritus—Prednisone—atopic dermatitis	4.03e-05	0.000451	CcSEcCtD
Haloperidol—Diarrhoea—Prednisone—atopic dermatitis	3.89e-05	0.000436	CcSEcCtD
Haloperidol—Nausea—Betamethasone—atopic dermatitis	3.88e-05	0.000435	CcSEcCtD
Haloperidol—Nausea—Dexamethasone—atopic dermatitis	3.88e-05	0.000435	CcSEcCtD
Haloperidol—Dizziness—Prednisone—atopic dermatitis	3.76e-05	0.000422	CcSEcCtD
Haloperidol—Vomiting—Prednisone—atopic dermatitis	3.62e-05	0.000405	CcSEcCtD
Haloperidol—Rash—Prednisone—atopic dermatitis	3.59e-05	0.000402	CcSEcCtD
Haloperidol—Dermatitis—Prednisone—atopic dermatitis	3.59e-05	0.000402	CcSEcCtD
Haloperidol—Headache—Prednisone—atopic dermatitis	3.57e-05	0.000399	CcSEcCtD
Haloperidol—Nausea—Prednisone—atopic dermatitis	3.38e-05	0.000379	CcSEcCtD
Haloperidol—HTR1D—Signaling by GPCR—CCR5—atopic dermatitis	1.1e-05	0.000397	CbGpPWpGaD
Haloperidol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.1e-05	0.000396	CbGpPWpGaD
Haloperidol—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.1e-05	0.000395	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CCR3—atopic dermatitis	1.09e-05	0.000394	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL5—atopic dermatitis	1.09e-05	0.000393	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	1.08e-05	0.000389	CbGpPWpGaD
Haloperidol—HTR2A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.08e-05	0.000388	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL5—atopic dermatitis	1.07e-05	0.000387	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL5—atopic dermatitis	1.07e-05	0.000386	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—CCR5—atopic dermatitis	1.06e-05	0.000383	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—CCL5—atopic dermatitis	1.06e-05	0.000382	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TAC1—atopic dermatitis	1.06e-05	0.000382	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NPS—atopic dermatitis	1.06e-05	0.000382	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—KIF3A—atopic dermatitis	1.05e-05	0.00038	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—CCR5—atopic dermatitis	1.05e-05	0.000379	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—CCL5—atopic dermatitis	1.05e-05	0.000377	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—CCR5—atopic dermatitis	1.04e-05	0.000374	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CXCR3—atopic dermatitis	1.04e-05	0.000374	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—KIF3A—atopic dermatitis	1.04e-05	0.000374	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	1.04e-05	0.000374	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NPS—atopic dermatitis	1.04e-05	0.000374	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—KIF3A—atopic dermatitis	1.04e-05	0.000373	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCR3—atopic dermatitis	1.03e-05	0.000371	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—CXCL10—atopic dermatitis	1.02e-05	0.000369	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NPS—atopic dermatitis	1.02e-05	0.000368	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TAC1—atopic dermatitis	1.02e-05	0.000368	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCR3—atopic dermatitis	1.02e-05	0.000366	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	1.02e-05	0.000366	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—CCR5—atopic dermatitis	1.01e-05	0.000365	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.01e-05	0.000363	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.01e-05	0.000363	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CXCR3—atopic dermatitis	1e-05	0.000361	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL5—atopic dermatitis	9.84e-06	0.000355	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TAC1—atopic dermatitis	9.73e-06	0.000351	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NPS—atopic dermatitis	9.73e-06	0.000351	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL5—atopic dermatitis	9.63e-06	0.000347	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—CCR5—atopic dermatitis	9.55e-06	0.000344	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GLB1—atopic dermatitis	9.54e-06	0.000344	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CXCR3—atopic dermatitis	9.54e-06	0.000344	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CMA1—atopic dermatitis	9.54e-06	0.000344	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCL11—atopic dermatitis	9.54e-06	0.000344	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL5—atopic dermatitis	9.48e-06	0.000342	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—CCR5—atopic dermatitis	9.42e-06	0.00034	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCL11—atopic dermatitis	9.38e-06	0.000338	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CMA1—atopic dermatitis	9.38e-06	0.000338	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CMA1—atopic dermatitis	9.36e-06	0.000338	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCL11—atopic dermatitis	9.36e-06	0.000338	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GLB1—atopic dermatitis	9.31e-06	0.000336	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CXCL10—atopic dermatitis	9.3e-06	0.000335	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—IL6—atopic dermatitis	9.24e-06	0.000333	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TAC1—atopic dermatitis	9.18e-06	0.000331	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NPS—atopic dermatitis	9.18e-06	0.000331	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ADSL—atopic dermatitis	9.15e-06	0.00033	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CXCL10—atopic dermatitis	9.15e-06	0.00033	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CXCL10—atopic dermatitis	9.13e-06	0.000329	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NPS—atopic dermatitis	9.05e-06	0.000327	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TAC1—atopic dermatitis	9.05e-06	0.000327	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL5—atopic dermatitis	9.05e-06	0.000326	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	9.02e-06	0.000325	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CXCR3—atopic dermatitis	9e-06	0.000325	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—STAT6—atopic dermatitis	8.97e-06	0.000323	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ADSL—atopic dermatitis	8.93e-06	0.000322	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—IL6—atopic dermatitis	8.93e-06	0.000322	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CXCR3—atopic dermatitis	8.88e-06	0.00032	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—STAT6—atopic dermatitis	8.82e-06	0.000318	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—CCL5—atopic dermatitis	8.81e-06	0.000318	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—STAT6—atopic dermatitis	8.8e-06	0.000318	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GLB1—atopic dermatitis	8.78e-06	0.000317	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GLB1—atopic dermatitis	8.7e-06	0.000314	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—CCL5—atopic dermatitis	8.67e-06	0.000313	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—CCL5—atopic dermatitis	8.65e-06	0.000312	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL5—atopic dermatitis	8.53e-06	0.000308	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.5e-06	0.000307	CbGpPWpGaD
Haloperidol—DRD2—GPCR ligand binding—CXCL8—atopic dermatitis	8.49e-06	0.000306	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL5—atopic dermatitis	8.42e-06	0.000304	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ADSL—atopic dermatitis	8.42e-06	0.000304	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	8.39e-06	0.000303	CbGpPWpGaD
Haloperidol—HTR2A—GPCR ligand binding—CXCL8—atopic dermatitis	8.36e-06	0.000302	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ADSL—atopic dermatitis	8.34e-06	0.000301	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—CXCL8—atopic dermatitis	8.34e-06	0.000301	CbGpPWpGaD
Haloperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	8.33e-06	0.0003	CbGpPWpGaD
Haloperidol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	8.31e-06	0.0003	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	8.21e-06	0.000296	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CXCL10—atopic dermatitis	8.08e-06	0.000291	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CCL5—atopic dermatitis	8e-06	0.000289	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—CCR5—atopic dermatitis	7.94e-06	0.000286	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CCL5—atopic dermatitis	7.87e-06	0.000284	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CCL5—atopic dermatitis	7.86e-06	0.000283	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—CCR5—atopic dermatitis	7.81e-06	0.000282	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—CCR5—atopic dermatitis	7.8e-06	0.000281	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCR3—atopic dermatitis	7.77e-06	0.00028	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CXCL10—atopic dermatitis	7.71e-06	0.000278	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCR3—atopic dermatitis	7.65e-06	0.000276	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCR3—atopic dermatitis	7.63e-06	0.000275	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GLB1—atopic dermatitis	7.44e-06	0.000268	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	7.33e-06	0.000264	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CXCL10—atopic dermatitis	7.27e-06	0.000262	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	7.22e-06	0.00026	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	7.21e-06	0.00026	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CXCL10—atopic dermatitis	7.18e-06	0.000259	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	7.18e-06	0.000259	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	7.14e-06	0.000257	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ADSL—atopic dermatitis	7.13e-06	0.000257	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	7.09e-06	0.000256	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CCR5—atopic dermatitis	7.08e-06	0.000255	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	7.07e-06	0.000255	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—CXCL8—atopic dermatitis	7.06e-06	0.000255	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	7e-06	0.000253	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CCL5—atopic dermatitis	6.96e-06	0.000251	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.95e-06	0.000251	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NPS—atopic dermatitis	6.93e-06	0.00025	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TAC1—atopic dermatitis	6.93e-06	0.00025	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	6.86e-06	0.000247	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	6.82e-06	0.000246	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NPS—atopic dermatitis	6.82e-06	0.000246	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TAC1—atopic dermatitis	6.8e-06	0.000245	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NPS—atopic dermatitis	6.8e-06	0.000245	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	6.79e-06	0.000245	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—IL2—atopic dermatitis	6.75e-06	0.000243	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	6.74e-06	0.000243	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NGF—atopic dermatitis	6.69e-06	0.000241	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	6.69e-06	0.000241	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CXCR3—atopic dermatitis	6.67e-06	0.000241	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	6.66e-06	0.00024	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	6.64e-06	0.00024	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PPARA—atopic dermatitis	6.59e-06	0.000238	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NGF—atopic dermatitis	6.55e-06	0.000236	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	6.52e-06	0.000235	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	6.5e-06	0.000235	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.45e-06	0.000233	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	6.44e-06	0.000232	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NGF—atopic dermatitis	6.44e-06	0.000232	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL5—atopic dermatitis	6.44e-06	0.000232	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	6.41e-06	0.000231	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	6.37e-06	0.00023	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	6.36e-06	0.000229	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	6.36e-06	0.000229	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.34e-06	0.000229	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL5—atopic dermatitis	6.34e-06	0.000229	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL5—atopic dermatitis	6.32e-06	0.000228	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	6.27e-06	0.000226	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CCR5—atopic dermatitis	6.27e-06	0.000226	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCL5—atopic dermatitis	6.26e-06	0.000226	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	6.23e-06	0.000225	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCL5—atopic dermatitis	6.18e-06	0.000223	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NGF—atopic dermatitis	6.15e-06	0.000222	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—IL2—atopic dermatitis	6.13e-06	0.000221	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	6.12e-06	0.000221	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	6.08e-06	0.000219	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	5.99e-06	0.000216	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	5.98e-06	0.000216	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	5.85e-06	0.000211	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NGF—atopic dermatitis	5.8e-06	0.000209	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	5.77e-06	0.000208	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GLB1—atopic dermatitis	5.74e-06	0.000207	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NGF—atopic dermatitis	5.72e-06	0.000206	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	5.7e-06	0.000206	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CCR5—atopic dermatitis	5.64e-06	0.000204	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CCR5—atopic dermatitis	5.57e-06	0.000201	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PPARA—atopic dermatitis	5.54e-06	0.0002	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL2—atopic dermatitis	5.52e-06	0.000199	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	5.51e-06	0.000199	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ADSL—atopic dermatitis	5.5e-06	0.000198	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	5.49e-06	0.000198	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL2—atopic dermatitis	5.44e-06	0.000196	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.42e-06	0.000195	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	5.4e-06	0.000195	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	5.4e-06	0.000195	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CXCL10—atopic dermatitis	5.39e-06	0.000195	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	5.31e-06	0.000192	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	5.07e-06	0.000183	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.8e-06	0.000173	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	4.78e-06	0.000173	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCL5—atopic dermatitis	4.73e-06	0.000171	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.72e-06	0.00017	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	4.72e-06	0.00017	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.71e-06	0.00017	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	4.65e-06	0.000168	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCL5—atopic dermatitis	4.64e-06	0.000167	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	4.59e-06	0.000165	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	4.51e-06	0.000163	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—IL2—atopic dermatitis	4.5e-06	0.000162	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NGF—atopic dermatitis	4.38e-06	0.000158	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	4.36e-06	0.000157	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NGF—atopic dermatitis	4.31e-06	0.000155	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NGF—atopic dermatitis	4.3e-06	0.000155	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	4.29e-06	0.000155	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—CXCL8—atopic dermatitis	4.28e-06	0.000154	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CCR5—atopic dermatitis	4.26e-06	0.000154	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	4.19e-06	0.000151	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CCR5—atopic dermatitis	4.18e-06	0.000151	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL2—atopic dermatitis	4.17e-06	0.00015	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	4.1e-06	0.000148	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL2—atopic dermatitis	4.09e-06	0.000148	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PPARA—atopic dermatitis	4.01e-06	0.000145	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	3.93e-06	0.000142	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	3.85e-06	0.000139	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	3.79e-06	0.000137	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PPARA—atopic dermatitis	3.78e-06	0.000137	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL2—atopic dermatitis	3.76e-06	0.000136	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	3.74e-06	0.000135	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL2—atopic dermatitis	3.68e-06	0.000133	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	3.66e-06	0.000132	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL2—atopic dermatitis	3.62e-06	0.000131	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	3.62e-06	0.00013	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	3.61e-06	0.00013	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—IL6—atopic dermatitis	3.6e-06	0.00013	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	3.55e-06	0.000128	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NFKBIA—atopic dermatitis	3.55e-06	0.000128	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	3.46e-06	0.000125	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL2—atopic dermatitis	3.46e-06	0.000125	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	3.44e-06	0.000124	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	3.41e-06	0.000123	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	3.39e-06	0.000122	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	3.37e-06	0.000121	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	3.33e-06	0.00012	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL2—atopic dermatitis	3.26e-06	0.000118	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—IL6—atopic dermatitis	3.24e-06	0.000117	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL2—atopic dermatitis	3.22e-06	0.000116	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—IL6—atopic dermatitis	3.2e-06	0.000115	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	3.18e-06	0.000115	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PPARA—atopic dermatitis	3.1e-06	0.000112	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PPARA—atopic dermatitis	3.02e-06	0.000109	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	3e-06	0.000108	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	2.96e-06	0.000107	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.85e-06	0.000103	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PPARA—atopic dermatitis	2.82e-06	0.000102	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	2.57e-06	9.29e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	2.53e-06	9.14e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CXCL8—atopic dermatitis	2.53e-06	9.12e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL2—atopic dermatitis	2.46e-06	8.88e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—IL6—atopic dermatitis	2.45e-06	8.83e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL2—atopic dermatitis	2.42e-06	8.74e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL2—atopic dermatitis	2.42e-06	8.72e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PPARA—atopic dermatitis	2.41e-06	8.71e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	2.41e-06	8.69e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—IL6—atopic dermatitis	2.4e-06	8.67e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	2.27e-06	8.17e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	2.23e-06	8.04e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MAPK8—atopic dermatitis	2.22e-06	8.02e-05	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—IL6—atopic dermatitis	2.21e-06	7.97e-05	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—IL6—atopic dermatitis	2.16e-06	7.8e-05	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—IL6—atopic dermatitis	2.13e-06	7.68e-05	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—IL6—atopic dermatitis	2.03e-06	7.33e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—IL6—atopic dermatitis	1.92e-06	6.91e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—IL6—atopic dermatitis	1.89e-06	6.82e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.86e-06	6.72e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—IL6—atopic dermatitis	1.45e-06	5.22e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—IL6—atopic dermatitis	1.42e-06	5.13e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—IL6—atopic dermatitis	1.42e-06	5.12e-05	CbGpPWpGaD
